Explore All Access
Check if your research matches the topics covered in IMMUNOTARGETS AND THERAPY?
- Degree of match
- Common matching concepts
- Additional journal recommendations
IMMUNOTARGETS AND THERAPY : Impact Factor & More
eISSN: 2253-1556pISSN: 2253-1556
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Topics Covered on IMMUNOTARGETS AND THERAPY
Antigen
Acetylcholine
Janus kinase inhibitor
Immune checkpoint inhibitors
Food allergy
Yersinia pestis
Pulmonary pathology
Chimeric antigen receptor
Immunotherapy
IMMUNOTARGETS AND THERAPY Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in IMMUNOTARGETS AND THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in IMMUNOTARGETS AND THERAPY
Comprehension of Calcitriol Levels in Pregnant Women With Latent Tuberculosis and Immune Function in their Newborns.
- 1 Apr 2024
- ImmunoTargets and therapy
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article.
- 1 Mar 2024
- ImmunoTargets and therapy
Cold Tumour Phenotype Explained Through Whole Genome Sequencing in Clinical Nasopharyngeal Cancer: A Preliminary Study.
- 1 Mar 2024
- ImmunoTargets and therapy
Thymic NK-Cells and Their Potential in Cancer Immunotherapy.
- 1 Mar 2024
- ImmunoTargets and therapy
Males' Access to Human Papillomavirus Vaccination in Resource-Limited Settings.
- 1 Feb 2024
- ImmunoTargets and therapy
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations.
- 1 Feb 2024
- ImmunoTargets and therapy
Comprehension of Calcitriol Levels in Pregnant Women With Latent Tuberculosis and Immune Function in their Newborns.
- 1 Apr 2024
- ImmunoTargets and therapy
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article.
- 1 Mar 2024
- ImmunoTargets and therapy
Cold Tumour Phenotype Explained Through Whole Genome Sequencing in Clinical Nasopharyngeal Cancer: A Preliminary Study.
- 1 Mar 2024
- ImmunoTargets and therapy
Thymic NK-Cells and Their Potential in Cancer Immunotherapy.
- 1 Mar 2024
- ImmunoTargets and therapy
Males' Access to Human Papillomavirus Vaccination in Resource-Limited Settings.
- 1 Feb 2024
- ImmunoTargets and therapy
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations.
- 1 Feb 2024
- ImmunoTargets and therapy
Compare Similar Journals with IMMUNOTARGETS AND THERAPY
Select Journals to Compare with IMMUNOTARGETS AND THERAPY
Total journals - 8
You can select up to 3 Journals at a time
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
International Journal of Molecular Sciences
Publisher: MDPI
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
Cancers
Publisher: MDPI
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Immunology
Publisher: WILEY
Journal of Allergy and Clinical Immunology
Publisher: MOSBY-ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
IMMUNOTARGETS AND THERAPY
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on IMMUNOTARGETS AND THERAPY
How long has IMMUNOTARGETS AND THERAPY been actively publishing? 
IMMUNOTARGETS AND THERAPY has been in operation since 2012 till date.
What is the publishing frequency of IMMUNOTARGETS AND THERAPY?
IMMUNOTARGETS AND THERAPY published with a Continuous publication frequency.
How many articles did IMMUNOTARGETS AND THERAPY publish last year?
In 2023, IMMUNOTARGETS AND THERAPY publsihed 12 articles.
What is the eISSN & pISSN for IMMUNOTARGETS AND THERAPY?
For IMMUNOTARGETS AND THERAPY, eISSN is 2253-1556 and pISSN is 2253-1556.
Who is the publisher of IMMUNOTARGETS AND THERAPY?
DOVE MEDICAL PRESS LTD is the publisher of IMMUNOTARGETS AND THERAPY.
